UBE2T and pancreatic neoplasm: For instance, 14, 15, and 16 inhibit the UBE2T/FANCL-mediated ubiquitination of FANCD2 in the FA pathway, while 17 targets gastric cancer and 18 targets pancreatic cancer (Figure 6D) [29,48,116].